nPhase raises $30 million Series D for its clinical data platform
Viking Global Investors led the financing for the Florida clinical research software company.
nPhase has closed a $30 million Series D led by Viking Global Investors. The company will use the investment to expand its enterprise clinical data business and develop its statistical computing, unified data management and agentic AI capabilities.
The Atlantic Beach, Florida company connects clinical data from study setup through regulatory submission. Its platform brings data from sites, laboratories, patients and devices into a shared environment for validation and analysis.
The financing is nPhase’s first equity raise since 2017. It follows the launch of a platform combining its Unified Data Management System and Statistical Computing Environment.
Use of funds
Expand enterprise clinical data business
Develop statistical computing and unified data management
Expand agentic AI capabilities